HOME >> BIOLOGY >> NEWS
Springer adds Genomic Medicine to biomedical publishing portfolio

Starting in 2007 Springer will publish a new journal entitled Genomic Medicine, providing a forum for reporting and discussing issues related to human and medical genomics. The wide scope of this peer-reviewed journal will reflect the rapidly expanding and broad nature of the field of genomics. With this launch, Springer will enhance its growing biomedical sciences publishing program.

Genomic Medicine will publish original papers and articles related to advances and developments in a wide range of genomic areas with proven and/or likely implications for the current and future practice of clinical medicine and population health. The journal will focus on applications of genomics to complex medical disorders, common cancers, psychiatric diseases and infectious diseases as well as the genome-based development and evaluation of new drugs. Also included will be papers dealing with specific issues related to the impact of medical genomics on community and public health, medical education and training, and ethical, legal and social matters. Dr. Dhavendra Kumar, Consultant in Clinical Genetics at the Institute of Medical Genetics at the University Hospital of Wales in Cardiff, United Kingdom is the Editor-in-Chief.

Peter Butler, Editorial Director for Life Sciences, said, "Genomic Medicine will differ from conventional human and medical genetic journals by concentrating exclusively on genomic applications to medical disorders. We are pleased to add Genomic Medicine to our portfolio, providing an outlet for specialists in all genome-related fields, from developmental biology to pharmacogenomics and from stem cell genomics to bioinformatics." Editor-in-Chief Dhavendra Kumar explained, "Numerous leading geneticists, biomedical scientists, clinicians and other related health professionals will serve on the editorial board. The journal has made a special provision to have a panel of Regional Editors representing different continents. This will ensure w
'"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
1-Dec-2006


Page: 1 2

Related biology news :

1. Springer launches Theoretical Ecology
2. Springer ecology book wins award for excellence
3. Springer author receives prestigious award in Beijing
4. Springer launches new journal, Cognitive Neurodynamics
5. Springer to publish new journal Systems and Synthetic Biology
6. Springer expands life science program with In Vitro journals
7. Springer author Alan Hastings wins Robert H. MacArthur Award
8. Springer acquires BioTribune Magazine and Biotribune.com
9. Springer editor and author Koki Horikoshi to receive 2006 Japan Academy Prize
10. Springer joins Katrina relief effort with eBooks donation worth more than $1 million
11. Genomics study provides insight into the evolution of unique human traits

Post Your Comments:
(Date:5/24/2013)... disease, scientists have focused among other factors on ... it is the accumulation of A-beta that causes the known ... the formation of A-beta is APP. Alessia Soldano and Bassem ... of APPL the fruit-fly version of APP in ... (VIB/KU Leuven): "We have discovered that APPL ensures that brain ...
(Date:5/23/2013)... Automated conserved noncoding sequence (CNS) discovery reveals differences ... , Within the genome of each species, there are ... in position and sequence over millions of years, but ... evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are ... the condensation of chromosomes, but the function of many ...
(Date:5/23/2013)... honored more than 165 staff for their creation, ... annual Intellectual Property Commercialization Recognition & Rewards Program ... laboratory named materials scientist Jun Liu Inventor of ... that can store large amounts of energy, ease ... time it takes to charge cell phones, electric ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
(Date:5/24/2013)... May 24, 2013 Vestiage, Inc. ... company focused on science-based research and development, sales ... cosmeceuticals and nutraceuticals, announced today that it is ... for the sale of Reluma Skin Illuminating Facial ... and application by sending an email to info(at)vestiageinc(dot)com ...
(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just praying that ... few doctors said he had a good chance of ... her now 20-month-old son, Kaiba. "At that point, we ... it and run with it." , They found hope ...
(Date:5/23/2013)... 23, 2013 Can economic incentives such ... motivate members of the public to increase their donations ... Johns Hopkins Carey Business School Assistant Professor Mario ... to a large body of recent research that supports ... 24, 2013, issue of Science that the World Health ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
Cached News: